ROYCE & ASSOCIATES LP - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 131 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$965,000
-8.1%
256,7250.0%0.01%0.0%
Q1 2018$1,050,000
-12.1%
256,7250.0%0.01%
-12.5%
Q4 2017$1,194,000
-34.5%
256,7250.0%0.01%
-33.3%
Q3 2017$1,823,000
-1.8%
256,7250.0%0.01%0.0%
Q2 2017$1,856,000
+17.4%
256,7250.0%0.01%
+20.0%
Q1 2017$1,581,000
+5.1%
256,7250.0%0.01%0.0%
Q4 2016$1,504,000
-10.8%
256,725
-19.2%
0.01%
-9.1%
Q3 2016$1,687,000
-43.6%
317,725
-29.7%
0.01%
-45.0%
Q2 2016$2,990,000
+41.7%
451,7250.0%0.02%
+53.8%
Q1 2016$2,110,000
+22.2%
451,725
+32.2%
0.01%
+30.0%
Q4 2015$1,726,000341,7250.01%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$30.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders